21 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-to-present-new-data-on-the-dual-efficacy-of-mazindol-er-in-fentanyl-reward-and-withdrawal-at-the-2025-ascp-annual-meeting-302461603.html
14 May 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-14-2025-10495.pdf
01 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-study-highlights-monthly-sublocade-as-a-potential-treatment-option-for-opioid-use-disorder-during-and-after-pregnancy-302444173.html
28 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/tharimmune-advances-th104-for-prophylaxis-against-weaponized-fentanyl-and-other-high-1019914
23 Apr 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-china-fentanyl-talks-hang-by-thread-amid-trade-war-2025-04-23/
15 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nls-pharmaceutics-announces-positive-results-from-study-ko-943-demonstrating-mazindol-reduces-fentanyl-induced-reward-in-animal-models-302428682.html